Maria Seriakov, CEO and founder of M bioserviceS, a young Austrian company dealing globally that specialises in logistics, regulatory affairs and quality control of biologics, discusses the challenges of navigating differing regulations across the globe as well as the how a hands-on approach ensures a product’s high quality. Furthermore, she highlights the exciting R&D collaboration to investigate bovine haemoglobin extract to be utilized for human blood transfusions.
What was the reasoning in 2013 to establish your own company?
"In the world of biologics, nature does not like to replicate itself and there will always be a need on the market to make available specific biological products that are consistent in terms of quality each and every time they are utilized."
